- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 85.05M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $5.05B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $5.07B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $499M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $400M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $321M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.88B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $5.08B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.72B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.3B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.34B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $8.96B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.92B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.38B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $14.27B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $14.08B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 87.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $161M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $52M |
| Capex | Q1 2025 · Mar 31, 2024 | $152M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $24M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.40 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.42 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $190M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $27M |
| Net Income | Q1 2025 · Mar 31, 2024 | $299M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $376M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $628M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.39B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $2.02B |